肝硬化患者营养评价方法研究进展*

doi:10.3969/j.issn.1672-5069.2014.06.031

Abstract

Abstract: Malnutrition in patients with liver cirrhosis is an important factor affecting the prognosis and mortality of these patients. In recent years,several nutritional evaluation methods are used in clinical practice, such as the body energy and substance metabolism assessment,anthropometric,biochemical and immunological indexes,and imaging evaluation. In this review, we summarized the application of these methods in order to provide references for assessing the nutritional status.

Key words: iver cirrhosis, Malnutrition, Nutritional assessment

Zheng Wenkai, Wang Maorong. Nutritional evaluation in patients with liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 672-680.

References

[1] Meng QH,Yu HW,Li J,et al. Inadequate nutritional intake and protein-energy malnutrition involved in acute and chronic viral hepatitis Chinese patients especially in cirrhosis patients. Hepatogastroenterology,2010,57（101）: 845-851.
[2] 汪茂荣. 重视肝硬化患者肝性脑病的营养管理：ISHEN共识介绍. 临床肝胆病杂志,2013,29（9）:649-651.
[3] 刘春梓,尚丽丹,谢欢. 消化道症状对重症肝病患者营养摄入的影响. 解放军护理杂志,2009,26（5A）:11-13 .
[4] 任建安,李宁,黎介寿. 能量代谢监测与营养物质需要量. 中国实用外科杂志,2001,21（10）:631-637.
[5] 邬明,王东. 慢性肝病患者静息能量消耗监测对营养支持治疗的意义. 中国社区医师（医学专业）,2010,12（14）:164.
[6] Figueiredo FA,De Mello Perez R,Kondo M. Effect of liver cirrhosis on body composition:evidence of significant depletion even in mild disease. Gastroenterol Hepatol,2005,20（2）:209-216.
[7] Campillo B,Richardet JP,Bories PN. Enteral nutrition in severely malnourished and anorectic cirrhotic patients in clinical practice. Gastroenterol Clin Biol,2005,29（6-7）:645-651.
[8] Campillo B,Richardet JP,Bories PN. Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol,2006,30（10）:1137-1143.
[9] Marchesini G,Moscatiello S,Di Domizio S,et al. Obesity-associated liver disease. Clin Endocrinol Metab,2008,93（11 Suppl 1）:S74-80.
[10] Muto Y,Sato S,Watanabe A,et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res,2006,35（3）:204-214.
[11] Peng S,Plank LD,McCall JL,et al. Body composition, muscle function,and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr,2007,85（5）:1257-1266.
[12] Houissa F,Salem M,Debbeche R,et al. Evaluation of nutritional status in patients with liver cirrhosis. Tunis Med,2010,88（2）: 76-79.
[13] Figueiredo FA,Dickson ER,Pasha TM,et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl,2000,6（5）: 575-581.
[14] Piquet MA,Ollivier I,Gloro R,et al. Nutritional indices in cirrhotic patients. Nutrition,2006,22（2）:216-217;author reply 218-219.
[15] Peng S,Plank LD,McCall JL,et al. Body composition, muscle function,and energy expenditure in patients with liver cirrhosis:a comprehensive study. Am J Clin Nutr,2007,85（5）:1257-1266.
[16] Amodio P,Bemeur C,Butterworth R,et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis:International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology,2013,58（1）:325-336.
[17] 凌轶群, 范建高. 肝硬化患者的营养评估. 肝脏,2007,12（4）:315-324.
[18] Figueiredo FA,Perez RM,Freitas MM,et al. Comparison of three methods of nutritional assessment in liver cirrhosis:subjective global assessment,traditional nutritional parameters,and body composition analysis. Gastroenterology,2006,41（5）:476-482.
[19] Chadalavada R,Sappati Biyyani RS,Maxwell J,et al. Nutrition in hepatic encephalopathy. Nutr Clin Pract,2010,25（3）:257-264.
[20] Detsky AS,McLaughlin JR,Baker JP,et al. What is subjective global assessment of nutritional status JPEN,1987,11（1）:8-13.
[21] Peng S,Plank LD,McCall JL,et al. Body composition, muscle function,and energy expenditure in patients with liver cirrhosis:a comprehensive study. Am J Clin Nutr,2007,85（5）:1257-1266.
[22] Fernandes SA,Bassani L,Nunes FF,et al. Nutritional assessment in patients with cirrhosis. Arq Gastroenterol,2012,49（1）: 19-27.
[23] Selberg O,Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects,hospitalized patients,and patients with liver cirrhosis. Eur J Appl Physiol,2002,86（6）: 509-516.
[24] Norman K,Schutz T,Kemps M,et al. The Subjective Global Assessment reliably identifies malnutrition-related muscle dysfunction. Clin Nutr,2005,24（1）:143-150.
[25] Filipovic BF,Gajic M,Milinic N,et al. Comparison of two nutritional assessment methods in gastroenterology patients. World J Gastroenterol,2010,16（16）:1999-2004.
[26] Taniguchi E,Kawaguchi T,Itou M,et al. Subjective global assessment is not sufficient to screen patients with defective hepatic metabolism. Nutrition,2011,27（3）:282-286.
[27] Naveau S,Belda E,Borotto E,et al. Comparison of clinical judgment and anthropometric parameters for evaluating nutritional status in patients with alcoholic liver disease. J Hepatol,1995,23（2）: 234-235.
[28] Kondrup J,Rasmussen HH,Hamberg O,et al. Nutritional risk screening（NRS 2002）:a new method based on an analysis of controlled clinical trials. Clin Nutr,2003,22（3）:321-336.
[29] Sorensen J,Kondrup J,Prokopowicz J,et al. EuroOOPS:an international,multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr,2008,27（3）:340-349.
[30] 郭迎迎, 褚燕君. 营养风险筛查2002对肝硬化患者营养评估的可行性探讨. 河南医学研究,2011,20（1）:58-60 .
[31] Raslan M,Gonzalez MC,Torrinhas RS,et al. Complementarity of Subjective Global Assessment（SGA） and Nutritional Risk Screening 2002（NRS 2002） for predicting poor clinical outcomes in hospitalized patients. Clin Nutr,2011,30（1）:49-53.
[32] Poulia KA,Yannakoulia M,Karageorgou D,et al. Evaluation of the efficacy of six nutritional screening tools to predict malnutrition in the elderly. Clin Nutr, 2012,31（3）:378-385.
[33] Morgan MY,Madden AM,Soulsby CT,et al. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology,2006,44（4）:823-835.
[34] Arora S,Mattina C,McAnenny C,et al. The development and validation of a nutritional prioritising tool for use in patients with chronic liver disease. Hepatology,2012,56 （Suppl 2）:S241 608.

Nutritional evaluation in patients with liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	. [J]. Journal of Practical Hepatology, 2019, 22(5): 624-635.
[6]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[7]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[8]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[11]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[12]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[13]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[14]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[15]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.